Table 1.
Considerations in islet transplantation.
| Allotransplantation | Autotransplantation | Stem cell transplantation | |
|---|---|---|---|
| Patient Population | Patients with type 1 diabetes and severe hypoglycemia, glycemic variability or microvascular complications | Patients with chronic pancreatitis undergoing pancreatectomy | Investigational; type 1 diabetes with potential application to other forms of diabetes |
| Source of Islet Material | Cadaveric islets | Autologous transplant | Human pluripotent stem cells (induced pluripotent stem cells or embryonic stem cells) |
| Limitations | - Immunosuppression required - Limited supply of donors |
- Limited cell mass, from one’s own diseased pancreas | -Remains investigational - Need to scale up to sufficient functional mass to reverse diabetes in humans |